Peapack Gladstone Financial Corp Pfizer Inc Transaction History

Peapack Gladstone Financial Corp

$6.94 Billion
Q3 2024

A detailed history of Peapack Gladstone Financial Corp transactions in Pfizer Inc stock. As of the latest transaction made, Peapack Gladstone Financial Corp holds 762,976 shares of PFE stock, worth $20.1 Million. This represents 0.32% of its overall portfolio holdings.

Number of Shares

762,976

Previous 615,571 23.95%

Holding current value

$20.1 Million

Previous $17.2 Million 28.2%

% of portfolio

0.32%

Previous 0.26%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 26, 2024	BUY	$27.7 - $31.39 $4.08 Million - $4.63 Million	147,405 Added 23.95%	762,976 $22.1 Million
Q2 2024 Aug 13, 2024	BUY	$25.26 - $29.6 $770,379 - $902,740	30,498 Added 5.21%	615,571 $17.2 Million
Q1 2024 May 10, 2024	SELL	$25.89 - $29.73 $197,825 - $227,166	-7,641 Reduced 1.29%	585,073 $16.2 Million
Q4 2023 Feb 13, 2024	BUY	$26.13 - $33.94 $1.87 Million - $2.43 Million	71,514 Added 13.72%	592,714 $17.1 Million
Q3 2023 Nov 14, 2023	SELL	$32.09 - $37.51 $505,930 - $591,382	-15,766 Reduced 2.94%	521,200 $17.3 Million
Q2 2023 Aug 14, 2023	SELL	$36.12 - $41.79 $34,783 - $40,243	-963 Reduced 0.18%	536,966 $19.7 Million
Q1 2023 May 15, 2023	SELL	$39.39 - $51.28 $486,939 - $633,923	-12,362 Reduced 2.25%	537,929 $22.6 Million
Q4 2022 Feb 14, 2023	SELL	$41.75 - $54.5 $870,654 - $1.14 Million	-20,854 Reduced 3.65%	550,291 $28.2 Million
Q3 2022 Nov 10, 2022	BUY	$43.76 - $53.42 $3.12 Million - $3.8 Million	71,198 Added 14.24%	571,145 $25 Million
Q2 2022 Aug 12, 2022	BUY	$46.53 - $55.17 $551,520 - $653,930	11,853 Added 2.43%	499,947 $26.2 Million
Q1 2022 May 16, 2022	SELL	$45.75 - $56.69 $10,934 - $13,548	-239 Reduced 0.05%	488,094 $25.3 Million
Q4 2021 Feb 15, 2022	SELL	$41.32 - $61.25 $1,156 - $1,715	-28 Reduced 0.01%	488,333 $28.8 Million
Q3 2021 Nov 15, 2021	BUY	$39.25 - $50.42 $2.6 Million - $3.34 Million	66,192 Added 15.68%	488,361 $21 Million
Q2 2021 Aug 16, 2021	SELL	$35.91 - $40.68 $83,778 - $94,906	-2,333 Reduced 0.55%	422,169 $16.5 Million
Q1 2021 May 14, 2021	BUY	$33.49 - $37.77 $3.46 Million - $3.9 Million	103,315 Added 32.17%	424,502 $15.4 Million
Q4 2020 Feb 16, 2021	BUY	$33.47 - $42.56 $1.16 Million - $1.47 Million	34,556 Added 12.06%	321,187 $11.8 Million
Q3 2020 Nov 16, 2020	BUY	$31.75 - $37.25 $653,732 - $766,977	20,590 Added 7.74%	286,631 $10.5 Million
Q2 2020 Aug 14, 2020	BUY	$30.12 - $36.54 $120,781 - $146,525	4,010 Added 1.53%	266,041 $8.7 Million
Q1 2020 May 15, 2020	BUY	$27.03 - $38.62 $226,808 - $324,060	8,391 Added 3.31%	262,031 $8.55 Million
Q4 2019 Feb 14, 2020	SELL	$32.92 - $37.36 $119,894 - $136,065	-3,642 Reduced 1.42%	253,640 $9.94 Million
Q3 2019 Nov 13, 2019	SELL	$32.49 - $42.13 $202,835 - $263,017	-6,243 Reduced 2.37%	257,282 $9.24 Million
Q2 2019 Aug 15, 2019	BUY	$36.98 - $41.52 $692,080 - $777,046	18,715 Added 7.64%	263,525 $11.4 Million
Q1 2019 May 15, 2019	BUY	$37.5 - $41.2 $6,900 - $7,580	184 Added 0.08%	244,810 $10.4 Million
Q4 2018 Feb 14, 2019	BUY	$38.47 - $43.86 $166,190 - $189,475	4,320 Added 1.8%	244,626 $10.7 Million
Q3 2018 Nov 14, 2018	BUY	$34.47 - $41.81 $141,637 - $171,797	4,109 Added 1.74%	240,306 $10.6 Million
Q2 2018 Aug 09, 2018	BUY	$32.98 - $35.16 $265,423 - $282,967	8,048 Added 3.53%	236,197 $8.57 Million
Q1 2018 May 10, 2018	BUY	$31.91 - $37.02 $98,569 - $114,354	3,089 Added 1.37%	228,149 $0
Q4 2017 Feb 14, 2018	BUY	$33.26 - $35.29 $718,183 - $762,016	21,593 Added 10.61%	225,060 $0
Q3 2017 Nov 14, 2017	BUY	$31.0 - $34.15 $122,915 - $135,404	3,965 Added 1.99%	203,467 $0
Q2 2017 Aug 14, 2017	BUY	N/A	199,502	199,502 $0

Others Institutions Holding PFE

# of Institutions

3,260

Shares Held

3.61B

Call Options Held

77.2M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $148B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Peapack Gladstone Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Peapack Gladstone Financial Corp with notifications on news.

Account

Peapack Gladstone Financial Corp Pfizer Inc Transaction History